Trial intelligence / Profile preview

Testosterone Treatment and Metabolic Syndrome Components

NCT01160341Phase 4Completed

Sponsor
Gulhane School of Medicine
Start
Aug 2009
Primary completion
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of testosterone in hypogonadotropic hypogonadism (HH), sponsored by Gulhane School of Medicine. Started Aug 2009; status: completed.

02

Drugs

testosterone
03

Conditions

hypogonadotropic hypogonadism (HH)

Beyond the preview

Go deeper on NCT01160341.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01160341.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call